Welcome and Plenary Session (8:00-9:00AM)
Gerald J. Hahn Achievement Award
Wayne Nelson, Wayne Nelson Statistical Consulting
ABSTRACT: The Hahn Award includes an invitation for the awardee to give a plenary talk. This is the most difficult talk I have had to develop. The Conference attendees are all talented, accomplished professionals. What could I say to enlighten them that they don’t already know? The Award recognizes my contributions to my clients’ applications, but old war stories have limited appeal. So I’ve decided to recognize my clients, friends, and colleagues contributions to me and have put together uncensored descriptions of key collaborators and clients and some work we have done. I will acknowledge them for their ideas which I published, and I will reveal those who really deserve the credit and what they did. Also, I will point out the dangers of publishing journal articles and books and discuss the power of data plots, life as an independent consultant, and the benefits of good clients and colleagues.
BIO:Dr. Wayne Nelson is a leading expert on analysis of reliability and accelerated test data. He consults on applications, gives training courses, and works as an expert witness. For 24 years he consulted across the General Electric Co. and received the Dushman Award of GE Corp. R&D for developments and applications of product reliability data analysis. He was elected a Fellow of the Amer. Statistical Assoc. (1973), the Amer. Soc. for Quality (1983), the IEEE (1988) for his innovative developments. He was awarded the 2003 Shewhart and 2010 Shainin Medals of ASQ, the 2005 Lifetime Achievement Award of the IEEE Reliability Society, and now the 2018 Hahn Award of ASA,for outstanding applications and developments of reliability methodology and contributions to reliability education. He authored three highly regarded books Applied Life Data Analysis (Wiley 2004), Accelerated Testing (Wiley 2004), Recurrent Events Data Analysis (SIAM 2003), two ASQ booklets, and 130 journal articles. He spends his free time dancing Argentine tango with angel partners.
Aerospace Technologies: Past, Present, and Future
Jerry Tarnacki, Senior VP (Ret.), Space Business Unit, Aerojet Rocketdyne
ABSTRACT: Coming soon.
BIO: Coming soon.
Youden Address (4:00-5:00PM)
Leveraging Industrial Statistics in the Data Revolution
L. Allison Jones-Farmer, Miami University
ABSTRACT: We are in the midst of a “data revolution” that is transforming our economy. This revolution is as large and profound as other major economic shifts from the introduction of the printing press to the industrial revolution. In this talk, we will briefly explore how the role of the “Data Scientist” has emerged and evolved and compare this to the evolution of the role of the “Industrial Statistician”, discussing the similarities and differences in these two fields. We will highlight a few disruptive technologies that are changing our roles as statisticians, including open source software like R and Python, Application Program Interfaces (APIs), GitHub, and Artificial Intelligence. We will discuss how we can leverage these modern technologies to transform our roles and better meet the needs of the data economy. Finally, we will discuss our duty to ethically and responsibly implement these tools, as well as to educate the next generation so that we are addressing important problems and so that the opportunities of the future belong to us all.
BIO: Dr. L. Allison Jones-Farmer is the Van Andel Professor of Analytics in the Department of Information Systems and Analytics and the Founder of the Center for Analytics and Data Science at Miami University in Oxford, Ohio. Her research focuses on developing practical methods for analyzing data in industrial and business settings. She is on the editorial review board of Journal of Quality Technologyand is a former Associate Editor of Technometrics. In 2014 she was awarded the Lloyd Nelson Award for the paper in Journal of Quality Technologywith the most immediate impact to practitioners. Dr. Jones-Farmer enjoys developing innovative curricula and teaching analytics and statistics to both undergraduate and graduate students. She has served on the faculty at the University of Miami in Coral Gables, Florida and at Auburn University in Auburn, Alabama. She has consulted with numerous organizations and enjoys working with companies to improve their analytics capabilities.
Statisticians Leading in a Data Science World
Lisa LaVange, ASA President
ABSTRACT: Statistics is a critical component of data science – enough so to cause ASA to seriously consider accreditation of the data science discipline. And data science is, practically speaking, a skill set that statisticians are more and more in need of for today’s marketplace. I will make the case for statisticians to assume a leadership role in navigating alternative data sources and structures, selecting appropriate data mining and machine learning tools, and visualizing and interpreting the results of data mining efforts. I will draw from examples in the clinical research area to illustrate how statistical leaders are best able to understand and explain the uncertainty arising from the use of real-world data in novel applications, but the general principles apply to other research areas as well. Training statisticians to lead, formally and informally, is essential for the future of our profession, and I will offer my views on ways this can be accomplished, including highlighting the planned initiatives of the ASA Statistical Leadership Institute.
BIO: Lisa LaVange, PhD, is Professor and Associate Chair of the Department of Biostatistics in the Gillings School of Global Public Health at the University of North Carolina at Chapel Hill. She is also director of the department’s Collaborative Studies Coordinating Center (CSCC), overseeing faculty, staff, and students involved in large-scale clinical trials and epidemiological studies coordinated by the center. From 2011 to 2017, Dr. LaVange was director of the Office of Biostatistics in the United States Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER). There, she oversaw more than 200 statisticians and other staff members involved in the development and application of statistical methodology for drug regulation. She was a leader in developing and assessing the effectiveness and appropriateness of innovative statistical methods intended to accelerate the process from drug discovery to clinical trials to FDA approval and patients’ benefit, with a particular focus on rare diseases. Prior to her government and academic experience, she spent 16 years in non-profit research and 10 years in the pharmaceutical industry. Dr. LaVange is an elected fellow of the American Statistical Association (ASA) and is the 2018 ASA President.
Wine & Cheese Reception with SPES Special Panel Session (3:15-5:15PM)
Statistical Engineering; What Is It and Where Is It Going
Roger Hoerl (Union College), William Brenneman (Procter and Gamble), and Geoff Vining (Virginia Tech)